| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8443727 | European Journal of Cancer | 2014 | 7 Pages |
Abstract
The HIF1A +1772 genetic polymorphism predicts a more aggressive prostate cancer behaviour, supporting the involvement of HIF1a in prostate cancer biological progression and ADT resistance. Molecular profiles using hypoxia markers may help predict clinically relevant prostate cancer and response to ADT.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Avelino Fraga, Ricardo Ribeiro, Paulo PrÃncipe, Carlos Lobato, Francisco Pina, Joaquina MaurÃcio, Cátia Monteiro, Hugo Sousa, F. Calais da Silva, Carlos Lopes, Rui Medeiros,